Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles

37Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Nanotechnology has received great attention since a decade for the treatment of different varieties of cancer. However, there is a limited data available on the cytotoxic potential of Temozolomide (TMZ) formulations. In the current research work, an attempt has been made to understand the anti-metastatic effect of the drug after loading into PLGA nanoparticles against C6 glioma cells.Nanoparticles were prepared using solvent diffusion method and were characterized for size and morphology. Diffusion of the drug from the nanoparticles was studied by dialysis method. The designed nanoparticles were also assessed for cellular uptake using confocal microscopy and flow cytometry. Results: PLGA nanoparticles caused a sustained release of the drug and showed a higher cellular uptake. The drug formulations also affected the cellular proliferation and motility. Conclusion: PLGA coated nanoparticles prolong the activity of the loaded drug while retaining the anti-metastatic activity. © 2014 Jain et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Jain, D. S., Athawale, R. B., Bajaj, A. N., Shrikhande, S. S., Goel, P. N., Nikam, Y., & Gude, R. P. (2014). Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles. DARU, Journal of Pharmaceutical Sciences, 22(1). https://doi.org/10.1186/2008-2231-22-18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free